A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
Titel:
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn’s Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial
Auteur:
van Linschoten, Reinier C. A. Jansen, Fenna M. Pauwels, Renske W. M. Smits, Lisa J. T. Atsma, Femke Kievit, Wietske de Jong, Dirk J. de Vries, Annemarie C. Boekema, Paul J. West, Rachel L. Bodelier, Alexander G. L. Gisbertz, Ingrid A. M. Wolfhagen, Frank H. J. Römkens, Tessa E. H. Lutgens, Maurice W. M. D. van Bodegraven, Adriaan A. Oldenburg, Bas Pierik, Marieke J. Russel, Maurice G. V. M. de Boer, Nanne K. Mallant-Hent, Rosalie C. ter Borg, Pieter C. J. van der Meulen-de Jong, Andrea E. Jansen, Jeroen M. Jansen, Sita V. Tan, Adrianus C. I. T. L. van der Woude, C. Janneke Hoentjen, Frank ,